capecitabine and cetuximab

DRUG2 trials

Sponsors

University of Medicine and Dentistry of New Jersey, Translational Genomics Research Institute

Conditions

Colorectal CancerMetastatic Colorectal Cancer

Phase 2

First-Line Capecitabine and Cetuximab for Metastatic Colorectal Ca in Elderly Patients

TerminatedNCT00251186

University of Medicine and Dentistry of New JerseyColorectal Cancer

Start: 2006-04-30End: 2006-04-30Target: 18Updated: 2010-01-26

Study of Capecitabine and Cetuximab as First-Line Therapy in Patients With Metastatic Wild Type Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Colorectal Cancer

WithdrawnNCT00954876

Translational Genomics Research InstituteMetastatic Colorectal Cancer

Start: 2009-08-31End: 2010-01-31Updated: 2022-10-20